2-methyl-4-(4-nitrophenyl)pyridine | 55218-69-4

• 分子结构分类: 有机化合物 - 有机杂环化合物 - 吡啶及其衍生物
• 英文名称: 2-methyl-4-(4-nitrophenyl)pyridine
• 英文别名: 2-methyl-4-(4-nitro-phenyl)-pyridine；4-(p-Nitrophenyl)-2-picolin；Pyridine, 2-methyl-4-(4-nitrophenyl)-
• CAS: 55218-69-4
• 化学式: C₁₂H₁₀N₂O₂
• 分子量: 214.224
• InChiKey: AYTGWDJKOUDXKZ-UHFFFAOYSA-N

物化性质

• 熔点：
  156-157 °C
• 沸点：
  343.4±27.0 °C(Predicted)
• 密度：
  1.216±0.06 g/cm3(Predicted)

计算性质

• 辛醇/水分配系数(LogP)：
  2.7
• 重原子数：
  16
• 可旋转键数：
  1
• 环数：
  2.0
• sp3杂化的碳原子比例：
  0.08
• 拓扑面积：
  58.7
• 氢给体数：
  0
• 氢受体数：
  3

反应信息

• 作为反应物：
  描述：

  2-methyl-4-(4-nitrophenyl)pyridine 在 palladium on activated charcoal 、 氢气 、 四丁基碘化铵 、 N,N-二异丙基乙胺 作用下， 以 甲醇 、 甲苯 为溶剂， 反应 48.0h， 生成 2-((4-(2-methylpyridin-4-yl)phenyl)amino)-N-(5-(pyrazin-2-yl)pyridin-2-yl)acetamide
  参考文献：
  名称：

  Wnt信号通路抑制剂及其应用

  摘要：

  本发明涉及一种具有Wnt信号通路抑制活性的杂环化合物，包括该化合物及其药学上可接受的盐、各种同位素、各种异构体或各种晶型结构，具有通式I所示的结构：本发明所涉及的化合物及其联合应用组合物可以有效抑制Wnt信号通路，能够用于治疗或预防与Wnt信号通路相关的病症。

  公开号：

  CN104876912B
• 作为产物：
  描述：

  4-溴-2-甲基吡啶 在 (1,1'-bis(diphenylphosphino)ferrocene)palladium(II) dichloride 、 potassium acetate 、 potassium carbonate 作用下， 以 四氢呋喃 、 1,4-二氧六环 、 水 为溶剂， 反应 27.0h， 生成 2-methyl-4-(4-nitrophenyl)pyridine
  参考文献：
  名称：

  Exploration of the linkage elements of porcupine antagonists led to potent Wnt signaling pathway inhibitors

  摘要：

  The Wnt signaling pathway is a pivotal developmental pathway. It operates through control of cellular functions such as proliferation, differentiation, migration and polarity. Aberrant Wnt signaling has been implicated in the formation and metastasis of tumors. Porcupine is a component of the Wnt signaling pathway. It is a member of the membrane-bound O-acyltransferase family of proteins. Porcupine catalyzes the palmitoylation of Wnt proteins, a process which is essential to their secretion and activity. Here we report a novel series of compounds obtained by a scaffold hybridization strategy from two known porcupine inhibitor classes. The leading compound 62 demonstrated subnanomolar (IC50 0.11 nM) inhibition of Wnt signaling in a paracrine cellular reporter gene assay. Compound 62 also potently inhibited Wnt secretion into culture medium, an indication of direct inhibition of the porcupine protein. Furthermore, compound 62 showed excellent chemical, plasma and liver microsomal stabilities. Collectively, these results strongly support further optimization of this novel scaffold to develop better Wnt pathway inhibitors. (C) 2015 Elsevier Ltd. All rights reserved.

  DOI：

  10.1016/j.bmc.2015.09.048

文献信息

• Synthesis and characterization of the first inhibitor of<i>N</i>-acylphosphatidylethanolamine phospholipase D (NAPE-PLD)
  作者：Beatrice Castellani、Eleonora Diamanti、Daniela Pizzirani、Piero Tardia、Martina Maccesi、Natalia Realini、Paola Magotti、Gianpiero Garau、Thomas Bakkum、Silvia Rivara、Marco Mor、Daniele Piomelli

  DOI：10.1039/c7cc07582k

  日期：——

  (NAPE-PLD) is a membrane-associated zinc enzyme that catalyzes the hydrolysis of N-acylphosphatidylethanolamines (NAPEs) into fatty acid ethanolamides (FAEs). Here, we describe the identification of the first small-molecule NAPE-PLD inhibitor, the quinazoline sulfonamide derivative 2,4-dioxo-N-[4-(4-pyridyl)phenyl]-1H-quinazoline-6-sulfonamide, ARN19874.

  Ñ -Acylphosphatidylethanolamine磷脂酶d（NAPE-PLD）是一种膜相关的，其催化水解酶锌Ñ -acylphosphatidylethanolamines（NAPEs）转换成脂肪酸乙醇酰胺（的FAE）。在这里，我们描述了第一个小分子NAPE-PLD抑制剂，喹唑啉磺酰胺衍生物2,4-二氧代-N- [4-（4-吡啶基）苯基] -1 H-喹唑啉-6-磺酰胺，ARN19874的鉴定。
• NOVEL SUBSTITUTED TRIAZOLE DERIVATIVES AS GAMMA SECRETASE MODULATORS
  申请人：Van Brandt Sven Franciscus Anna

  公开号：US20120295891A1

  公开（公告）日：2012-11-22

  The present invention is concerned with novel substituted triazole derivatives of Formula (I) wherein Het 1 , R 1 , R 2 , A 1 , A 2 , A 3 , A 4 , L 1 , and L 2 have the meaning defined in the claims. The compounds according to the present invention are useful as gamma secretase modulators. The invention further relates to processes for preparing such novel compounds, pharmaceutical compositions comprising said compounds as an active ingredient as well as the use of said compounds as a medicament.

  本发明涉及具有以下式（I）的新型取代三唑衍生物，其中Het1，R1，R2，A1，A2，A3，A4，L1和L2的含义如权利要求中所定义。根据本发明的化合物可用作γ-分泌酶调节剂。本发明还涉及制备这种新型化合物的方法，包括将所述化合物作为活性成分的药物组合物以及将所述化合物用作药物的用途。
• Wnt信号通路抑制剂及其应用
  申请人：苏州云轩医药科技有限公司

  公开号：CN104876912B

  公开（公告）日：2017-07-21

  本发明涉及一种具有Wnt信号通路抑制活性的杂环化合物，包括该化合物及其药学上可接受的盐、各种同位素、各种异构体或各种晶型结构，具有通式I所示的结构：本发明所涉及的化合物及其联合应用组合物可以有效抑制Wnt信号通路，能够用于治疗或预防与Wnt信号通路相关的病症。
• [EN] NOVEL SUBSTITUTED TRIAZOLE DERIVATIVES AS GAMMA SECRETASE MODULATORS<br/>[FR] NOUVEAUX DÉRIVÉS DE TRIAZOLE SUBSTITUÉS COMME MODULATEURS DE GAMMA SECRÉTASE
  申请人：ORTHO MCNEIL JANSSEN PHARM

  公开号：WO2011086099A1

  公开（公告）日：2011-07-21

  The present invention is concerned with novel substituted triazole derivatives of Formula (I) wherein Het1, R1, R2, A1, A2, A3, A4, L1, and L2 have the meaning defined in the claims. The compounds according to the present invention are useful as gamma secretase modulators. The invention further relates to processes for preparing such novel compounds, pharmaceutical compositions comprising said compounds as an active ingredient as well as the use of said compounds as a medicament.

  本发明涉及一种新型的Formula (I)中的取代三唑衍生物，其中Het1、R1、R2、A1、A2、A3、A4、L1和L2的含义如权利要求中所定义。根据本发明的化合物可用作γ-分泌酶调节剂。本发明还涉及制备这种新型化合物的方法，包括将所述化合物作为活性成分的药物组合物以及将所述化合物用作药物的用途。
• [EN] NOVEL SUBSTITUTED BICYCLIC TRIAZOLE DERIVATIVES AS GAMMA SECRETASE MODULATORS<br/>[FR] NOUVEAUX DÉRIVÉS DE TRIAZOLE BICYCLIQUES SUBSTITUÉS COMME MODULATEURS DE GAMMA SECRÉTASE
  申请人：ORTHO MCNEIL JANSSEN PHARM

  公开号：WO2011086098A1

  公开（公告）日：2011-07-21

  The present invention is concerned with novel substituted bicyclic triazole derivatives of Formula (I) wherein Het1, R1, R2, A1, A2, A3, A4, L1, and L2 have the meaning defined in the claims. The compounds according to the present invention are useful as gamma secretase modulators. The invention further relates to processes for preparing such novel compounds, pharmaceutical compositions comprising said compounds as an active ingredient as well as the use of said compounds as a medicament.

  本发明涉及一种新型的取代的Formula (I)中的双环三唑衍生物，其中Het1、R1、R2、A1、A2、A3、A4、L1和L2的含义如权利要求中所定义。根据本发明的化合物可用作γ-分泌酶调节剂。本发明还涉及制备这种新型化合物的方法，包括将所述化合物作为活性成分的药物组合物以及将所述化合物用作药物的用途。